Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
University of Pittsburgh
SWOG Cancer Research Network
IFOM ETS - The AIRC Institute of Molecular Oncology
City of Hope Medical Center
Myriad Genetic Laboratories, Inc.
UNC Lineberger Comprehensive Cancer Center
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC